SSA
LLY icon

SSA Swiss Advisors’s Eli Lilly LLY Stock Holding History

SSA Swiss Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97M Hold
4,100
– – 1.87% 18
2026
Q1 		$3.75M Hold
4,100
– – 1.74% 20
2025
Q4 		$4.42M Hold
4,100
– – 2.06% 14
2025
Q3 		$3.12M Hold
4,100
– – 1.45% 31
2025
Q2 		$3.26M Buy
+4,100
New +$3.19M 1.57% 27

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSA Swiss Advisors's LLY Position: Q2 2026 in Review

SSA Swiss Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 4,100 shares worth $4.97M. The position accounts for 1.87% of the portfolio, ranked #18.

SSA Swiss Advisors first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SSA Swiss Advisors held 4,100 shares of Eli Lilly worth $4.97M as of Q2 2026.
  • SSA Swiss Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.87% of SSA Swiss Advisors's portfolio in Q2 2026, its #18 holding.
  • SSA Swiss Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SSA Swiss Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.